Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00251511
Status:
TERMINATED
Last Update Posted:
2012-05-11
First Post:
2005-11-08
Brief Title:
A Phase II Trial of Trisenox Plus Thalomid as Treatment in Patients With Myelodysplastic Syndrome
Sponsor:
Veeda Oncology
Organization:
Veeda Oncology
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Myelodysplastic Syndrome |
Keywords: